,Date,Title,URL,Journal,Severe,Severe lower bound,Severe upper bound,Severe p-value,Severe Significant,Severe Adjusted,Severe Calculated,Fatality,Fatality lower bound,Fatality upper bound,Fatality p-value,Fatality Significant,Fatality Adjusted,Fatality Calculated,Multivariate adjustment,Design,Sample,Study population,Added on,Critical only,Discharged vs. death?
0,2020-03-30,"Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China",https://doi.org/10.1101/2020.03.25.20037721,medRxiv,OR 6.53,2.75,15.5,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,323,"Tianyou Hospital from January 8 to February 20, 2020",4/10/2020,Y,N
1,2020-03-30,"Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China",https://doi.org/10.1101/2020.03.25.20037721,medRxiv,OR 2.49,1.07,5.79,,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,323,"Tianyou Hospital from January 8 to February 20, 2020",4/10/2020,N,N
2,2020-03-11,Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China,https://doi.org/10.1007/s00392-020-01626-9,Clinical Research in Cardiology,RR: 3.30,2.03,5.36,<0.01,Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,5 studies enrolling 1514 patients,EMBASE and PubMed were searched from December 2019 to February 2020,4/27/2020,N,N
3,2020-02-25,"Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study",https://doi.org/10.1101/2020.02.22.20026500,medRxiv,OR 1.27,0.44,3.65,0.65,Not Significant,Not Adjusted,Calculated,,,,,,,,,Case series,214,Union Hospital of Huazhong University of Science and Technology in Wuhan from 16 January to 19 February 2020,4/10/2020,N,N
